# Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics

> **NCT06630273** · — · NOT_YET_RECRUITING · sponsor: **Canadian Cancer Trials Group** · enrollment: 120 (estimated)

## Conditions studied

- Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06630273
- **Lead sponsor:** Canadian Cancer Trials Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06630273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06630273, "Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06630273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*